Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: New York
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Emergent Biosolutions Inc

+ Add to Watchlist

EBS:US

30.7400 USD 1.0500 3.54%

As of 20:04:07 ET on 05/01/2015.

Snapshot for Emergent Biosolutions Inc (EBS)

Open: 29.8000 Day's Range: 29.7000 - 30.8900 Volume: 202,307
Previous Close: 29.6900 52wk Range: 19.3100 - 31.3300 1-Yr Rtn: +17.46%

Stock Chart for EBS

No chart data available.
  • EBS:US 30.7400
  • 1D
  • 1M
  • 1Y
29.6900
Interactive EBS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for EBS

Current P/E Ratio (ttm) 33.1104
Estimated P/E(12/2015) 31.3673
Relative P/E vs. SPX 1.7905
Earnings Per Share (USD) (ttm) 0.9284
Est. EPS (USD) (12/2015) 0.9800
Est. PEG Ratio -
Market Cap (M USD) 1,178.08
Shares Outstanding (M) 38.32
30 Day Average Volume 247,113
Price/Book (mrq) 2.0954
Price/Sale (ttm) 2.5563
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/07/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for EBS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for EBS

Emergent Biosolutions, Inc. develops and produces immunobiotics, pharmaceutical products that assist the body's immune system to prevent or treat disease. The Company produces a vaccine for anthrax.

Fuad El-HibriChairmanDaniel J Abdun-NabiPresident/CEO
Adam HaveyExec VP/President:BiodefenseBarry A LabingerExec VP/Pres:Biosciences
More Company Profile & Key Executives for EBS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil